Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease

2005 ◽  
Vol 40 (10) ◽  
pp. 925-931 ◽  
Author(s):  
Akio Ido ◽  
Masatsugu Numata ◽  
Mayumi Kodama ◽  
Hirohito Tsubouchi
2005 ◽  
Vol 288 (4) ◽  
pp. G729-G735 ◽  
Author(s):  
Koushi Oh ◽  
Yuji Iimuro ◽  
Masaharu Takeuchi ◽  
Yasufumi Kaneda ◽  
Tsuyoshi Iwasaki ◽  
...  

Hepatocyte growth factor (HGF), a multifunctional cytokine, accelerates intestinal epithelial proliferation. We studied the effects of HGF in mice with trinitrobenzene sulfonic acid-induced colitis, which shows clinical and molecular resemblance to Crohn's disease. Mice with colitis repeatedly were transfected intramuscularly with human HGF cDNA. Weight, survival, histopathology, proinflammatory cytokine mRNAs, and leukocyte infiltration were assessed. Treatment with HGF cDNA induced tyrosine phosphorylation of intestinal c-Met/HGF receptors, inhibited apoptosis, and promoted mitosis in intestinal epithelial cells, accelerating intestinal epithelial restoration and suppressing inflammation. Transfection with HGF cDNA markedly suppressed intestinal mRNA expression of T-helper 1 cytokines such as interleukin-12 and -1β, interferon-γ, and tumor necrosis factor-α. Numbers of total and CD4-positive T cells, neutrophils, and myloperoxidase activity in intestinal epithelium were diminished by HGF gene transfer, which also prevented weight loss, and improved survival. HGF might prove useful for controlling inflammatory bowel disease.


Sign in / Sign up

Export Citation Format

Share Document